Abstract
In this study fibromyalgia sufferers were randomly administered a combination of monoamine -oxidase inhibitors (MAOIs) -A/B with 5-HTP, 5-HTP alone, MAOIs-A/B alone, or the tricyclic drug amitriptyline in order to compare the efficacy of these treatments. The benefits on the painful syndrome were assessed by using Visual Analogic Scale score rating from 0 to 4. The combination of MAOIs with 5-HTP significantly improved fibromyalgia syndrome as determined by Visual Analogic Scale whereas the other treatments yielded poorer benefits. No subject withdrew from the trial due to adverse effects, even if some sleep disturbances and mild stomach-ache were reported. The tolerability of the association MAOIs/5-HTP was good, although a transient cheese effect occurred in one of the patients treated with MAOIs as well as in a patient treated with the association MAOIs and 5-HTP. No one of these two cases was due to pharmacological dietetic mistake of the patient. In both the cases the transient hypertension was associated to very dramatic emotional events.
The benefits obtained by using the combination of MAOIs with 5-HTP can be explained with a treatment-induced enhancement of aminergic and serotonergic transmission. The recently shown high prevalence of migraine in the population of fibromyalgia sufferers, suggests a common ground shared by fibromyalgia and migraine. Migraine has been demonstrated to be characterized by a defect in the serotonergic and adrenergic systems. A parallel dramatic failure of serotonergic systems and a defect of adrenergic transmission have been evidenced to affect fibromyalgia sufferers too. Enhancing serotonergic analgesia while increasing adrenergically mediated analgesia seems to be an important tool in fibromyalgia. Treatment consisting with the association MAOIs/5-HTP is aimed at enhancing serotonergic/adrenergic transmission by inducing an up-regulation of serotonergic/adrenergic receptors and a simultaneous increase of serotonin levels in the central nervous system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bastos, S.B., de Almeida-Filho, N., Santana, V.S., 1993, Prevalence of headache as a symptom in an urban area of Salvador, Bahia. Arq Neuropsiquiatr, 51 (3): 307
Boulton, A. A., Juorrio, A.V., Peterson, I.A., 1990, Phenylethylamine in the CNS: effects ofmonoamine oxidase inhibiting drugs, deuterium substitution and lesions and its role in the neuromodulation of catecholaminergic neurotransmission. J Neural Trans29: 119
Creese, I., Sibley, D.R., 1981, Receptor adaptations to centrally acting drugs. Ann Rev Pharmacol Toxicol21: 357
Cremata, V,Y Koe, B.K., 1966, Clinical pharmacological evaluation of p-chlorophenylalanine: a new serotonin-depleting agent. Clin Pharmacol Ther7: 768
Curzon, G., 1979, Relationship between plasma, CSF and brain tryptophan. J Neural Transm15: 81
De Montis, M.G., Olianas, M,C,. Mulas, G., Tagliamonte, A., 1977, Evidence that only free serum tryptophan exchanges with the brain. Phar Res Commun9 (2): 215
Foster, A.C., Vezzani, A.M., French, E.D., Schwarcz, R., 1984, Kynurenic acid blocks neurotoxicity and seizures in rats by the related brain metabolite quinolinic acid. Neurosci Lett48: 273
Handworker, H.O., 1993, Mechanisms of cutaneous and subcutaneous hyperalgesia, in “New Trends in Referred Pain and Hyperalgesia”, Vecchiet L, Albe-Fessard D, Lindblom U, eds, Elsevier, Amsterdam (1993)
Heinonen, E.H., Lammintausta, R.A., 1991, A review of the pharmacology of selegiline. Acta Neurol Scand84 (136): 44
International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1998, 8 (7)
King, R., 1980, Pain and tryptophan. JNeurosurg53: 44
Koshikawa, F., Koshikawa, N., Stephenson, J.D., 1985, Effects of antidepressant drugs and cortical 5-HT2 receptors and wet-dog shakes in rats. Eur J Pharmacol118: 273
Lance, J.W ., 1992, Possible role of serotonin in the migraine syndrome, in: “Advances in Pain Research and Therapy”, Sicuteri F., Terenius L., Vecchiet L., Maggi CA.,eds, Raven Press, New York
Mc Cain, G.A., 1990, Management of fibromyalgia syndrome. In: JR Fricton, A Essam (eds), Advances in Pain Research and Therapy, Vol 17, Raven Press, New York
Moroni, F., Lombardi, G., Carla, V., Moneti G., 1984, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Res295: 352
Munoz, M., Dumas, M., Boutros-Toni, F, Coquelle, D., Nicolas, A., Ndzanga, E„ Boa, F, Vallat, J.M., Dartigues, J.F., 1993, Prevalence of headache in a representative sample of the population in a French department (Haute-Vienne-Limousin) Headache33 (10) 521
Nicolodi, M., Sicuteri, F., 1992, Central panalgia as an expression of systemic analgodeficiency. in: “Advances in Pain Research and Therapy”, F. Sicuteri, L Terenius, L Vecchiet, C A Maggi, eds, Raven Press, New York
Panagiotidis, G., Stenstrom, A., Lundquist, I., 1993, Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse. Eur J Pharmacol233 (3): 285
Perkins, M.N., Stone, T.W., 1982, An iontophoretic investigation of the actions of convulsant kynurenines and the interaction with endogenous excitant quinolinic acid. Brain Res247: 184
Rajiv, J., Welch, K.M.A., D’Andrea, G., 1989, Serotonergic hypofiinction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia9: 18
Seltzer, S., 1985, Pain relief by dietary manipulations and tryptophan supplements. J Endodontics11 (10): 449
Sicuteri, F., 1971, Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm3 (4): 401
Sicuteri, F., 1971, Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm3(4): 401
Sicuteri, F., Michelacci, S,. Franchi, G., 1962, Contributo alia caratterizzazione della farmacologia della reserpina sul sistema nervoso centrale. antagonismo di un bloccante adrenergico sul fenomeno dell’eccitazione paradossa da reserpina nel topo. Boll Soc Ital Biol Sper38 (8): 381
Sicuteri, F., Fanciullacci, M., Del Bianco, PL., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467
Sicuteri, F., Fanciullacci, M., Del Bianco, P.L., 1965, Variata reattivita alia 5-idrossitriptamina ed alia nor-adrenalina da anti monoamino ossidasici nell’ uomo. Boll Soc Ital Biol Sper41 (9): 467
Sicuteri, F., Anselmi, B., Fanciullacci, M., 1974, The serotonin (5-HT) theory of migraine. Adv Neurol4: 383
Sicuteri, F., Anselmi, B., Del Bianco, P.L., 1978, Systemic non organic central pain with decentralization super-sensitivity. Headache18: 133
Sicuteri, F., Nicolodi, M., Fusco, B.M., 1984, Abnormal sensitivity to agonists, antagonists and releasers, in: “Basic Mechanism of headache”, JOlesen, L Edvinnsson, eds, Elsevier, Amsterdam
Sicuteri, F., Nicolodi, M., 1991, Serotonin: a “Sphynx” in migraine, in, “Headache and depression: serotonin pathways as a common clue”, Nappi G et al., eds, Raven Press, New York
Simons, D ., 1990, Muscular pain syndromes, in: “Advances in Pain Research and Therapy”, JR Fricton, A Essam,eds, Raven Press, New York
Wang, R.I.H., Wiesen, R.L., Treul, S., Stockdale, S., 1976, Brief anxiety rating test J Clin Pharmacol16 (2/3): 99 - 105
Wolfe, F., Smythe, H.A., Yunus, M.B., 1990, The american college of rheumatology 1990 Criteria for the classification of fibromyalgia, report of the multicenter criteria committee. Arthritis Rheum33: 160
Zimmermann, M ., 1991, Pathophysiological mechanisms of fibromyalgia. Clin J Pain7(1): 8
Zung, WW . 1965 A self rating depression scale. Arch Gen Psychiatry12: 163–65
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Nicolodi, M., Sicuteri, F. (1996). Fibromyalgia and Migraine, Two Faces of the Same Mechanism. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_58
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0381-7_58
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8026-9
Online ISBN: 978-1-4613-0381-7
eBook Packages: Springer Book Archive